U.S. markets open in 2 hours 17 minutes
  • S&P Futures

    4,396.25
    +1.75 (+0.04%)
     
  • Dow Futures

    34,905.00
    -48.00 (-0.14%)
     
  • Nasdaq Futures

    14,969.75
    +22.00 (+0.15%)
     
  • Russell 2000 Futures

    2,198.80
    +12.10 (+0.55%)
     
  • Crude Oil

    71.97
    +0.32 (+0.45%)
     
  • Gold

    1,798.40
    -1.40 (-0.08%)
     
  • Silver

    24.83
    +0.18 (+0.73%)
     
  • EUR/USD

    1.1809
    -0.0017 (-0.14%)
     
  • 10-Yr Bond

    1.2340
    0.0000 (0.00%)
     
  • Vix

    18.93
    +1.35 (+7.68%)
     
  • GBP/USD

    1.3877
    -0.0002 (-0.01%)
     
  • USD/JPY

    110.0360
    +0.2690 (+0.25%)
     
  • BTC-USD

    40,372.66
    +2,799.45 (+7.45%)
     
  • CMC Crypto 200

    945.69
    +69.46 (+7.93%)
     
  • FTSE 100

    7,007.29
    +11.21 (+0.16%)
     
  • Nikkei 225

    27,581.66
    -388.56 (-1.39%)
     

Top Ranked Momentum Stocks to Buy for November 17th

·3 min read

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, November 17th:

Semler Scientific, Inc. (SMLR): This company that develops, manufactures, and markets proprietary products that assist healthcare providers has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 61.7% over the last 60 days.

 

Semler Scientific Inc. Price and Consensus

Semler Scientific Inc. Price and Consensus
Semler Scientific Inc. Price and Consensus

Semler Scientific Inc. price-consensus-chart | Semler Scientific Inc. Quote

 

Semler Scientific’s shares gained 36.6% over the last one month compared with the S&P 500’s growth of 4.1%. The company possesses a Momentum Score of A.

 

Semler Scientific Inc. Price

Semler Scientific Inc. Price
Semler Scientific Inc. Price

Semler Scientific Inc. price | Semler Scientific Inc. Quote

 

Fulgent Genetics, Inc. (FLGT): This genetic testing services provider has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing more than 100% over the last 60 days.

 

Fulgent Genetics, Inc. Price and Consensus

Fulgent Genetics, Inc. Price and Consensus
Fulgent Genetics, Inc. Price and Consensus

Fulgent Genetics, Inc. price-consensus-chart | Fulgent Genetics, Inc. Quote

 

Fulgent Genetics’ shares gained nearly 29% over the last one month. The company possesses a Momentum Score of A.

 

Fulgent Genetics, Inc. Price

Fulgent Genetics, Inc. Price
Fulgent Genetics, Inc. Price

Fulgent Genetics, Inc. price | Fulgent Genetics, Inc. Quote

 

Charles & Colvard, Ltd. (CTHR): This company that manufacture, market and distribute moissanite jewels has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing more than 100% over the last 60 days.

 

Charles & Colvard Ltd Price and Consensus

Charles & Colvard Ltd Price and Consensus
Charles & Colvard Ltd Price and Consensus

Charles & Colvard Ltd price-consensus-chart | Charles & Colvard Ltd Quote

 

Charles & Colvard’s shares gained 15.7% over the last one month. The company possesses a Momentum Score of A.

 

Charles & Colvard Ltd Price

Charles & Colvard Ltd Price
Charles & Colvard Ltd Price

Charles & Colvard Ltd price | Charles & Colvard Ltd Quote

 

Regional Management Corp. (RM): This diversified consumer finance company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 40.3% over the last 60 days.

 

Regional Management Corp. Price and Consensus

Regional Management Corp. Price and Consensus
Regional Management Corp. Price and Consensus

Regional Management Corp. price-consensus-chart | Regional Management Corp. Quote

 

Regional Management’s shares gained 15.9% over the last one month. The company possesses a Momentum Score of A.

 

Regional Management Corp. Price

Regional Management Corp. Price
Regional Management Corp. Price

Regional Management Corp. price | Regional Management Corp. Quote

 

See the full list of top ranked stocks here

Learn more about the Momentum score and how it is calculated here.

Legal Marijuana: An Investor’s Dream

Imagine getting in early on a young industry primed to skyrocket from $17.7 billion in 2019 to an expected $73.6 billion by 2027. 

Although marijuana stocks did better as the pandemic took hold than the market as a whole, they’ve been pushed down. This is exactly the right time to get in on selected strong companies at a fraction of their value before COVID struck. Zacks’ Special Report, Marijuana Moneymakers, reveals 10 exciting tickers for urgent consideration.

Download Marijuana Moneymakers FREE >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Semler Scientific Inc. (SMLR) : Free Stock Analysis Report
 
Regional Management Corp. (RM) : Free Stock Analysis Report
 
Fulgent Genetics, Inc. (FLGT) : Free Stock Analysis Report
 
Charles & Colvard Ltd (CTHR) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research